TNFSF10 and cancer: In multivariate models, there were only two outcomes for which lower levels of senescence biomarkers were associated with higher risk; lower serum concentrations of TRAIL were associated with greater risk of mortality, and lower levels of TRAIL and uPAR were associated with greater risk for cancer.